KCNB1: Difference between revisions

From WikiMD's Medical Encyclopedia

CSV import
 
No edit summary
 
(5 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[file:4jta.1_1_chimera_colorbysym_1000_1000.png|thumb|4jta.1 1 chimera colorbysym 1000 1000]] [[file:4jta.1_0_chimera_colorbysym_1000_1000.png|thumb|4jta.1 0 chimera colorbysym 1000 1000|left]] '''KCNB1''' is a gene that encodes the potassium voltage-gated channel subfamily B member 1 protein, also known as Kv2.1. This protein is a crucial component of the voltage-gated potassium channels, which are essential for the proper functioning of neurons and other excitable cells.
 
{{Infobox gene
| name = KCNB1
| image = <!-- Image of the gene or protein, if available -->
| caption = <!-- Caption for the image -->
| HGNCid = 6258
| symbol = KCNB1
| alt_symbols = Kv2.1
| EntrezGene = 3745
| OMIM = 616056
| RefSeq = NM_004975
| UniProt = Q14721
| chromosome = 20
| arm = q
| band = 13
}}
 
'''KCNB1''' is a gene that encodes the voltage-gated potassium channel subunit Kv2.1. This channel is crucial for the regulation of electrical signaling in neurons and other excitable cells.  


== Function ==
== Function ==
The KCNB1 gene product, Kv2.1, is involved in the regulation of electrical signaling in neurons. It contributes to the repolarization phase of the action potential, which is critical for the proper timing of neuronal firing. Kv2.1 channels are known for their role in maintaining the resting membrane potential and controlling the excitability of neurons.
The [[KCNB1]] gene product, Kv2.1, is a major component of the delayed rectifier potassium current in neurons. It plays a critical role in repolarizing the membrane potential following an action potential, thereby influencing neuronal excitability and firing patterns.
 
== Clinical Significance ==
Mutations in the [[KCNB1]] gene have been associated with a range of neurological disorders, including developmental and epileptic encephalopathy. These mutations can lead to altered channel function, which disrupts normal neuronal activity and can result in seizures and developmental delays.


== Structure ==
== Structure ==
Kv2.1 is a transmembrane protein that forms a tetrameric complex. Each subunit of the channel consists of six transmembrane segments (S1-S6) with a pore loop between S5 and S6. The S4 segment acts as the voltage sensor, which responds to changes in membrane potential and triggers the opening or closing of the channel.
Kv2.1 channels are composed of four identical subunits, each containing six transmembrane segments. The channel's pore is formed by the arrangement of these subunits, allowing selective passage of potassium ions.


== Expression ==
== Expression ==
KCNB1 is predominantly expressed in the [[central nervous system]], particularly in the [[cerebral cortex]], [[hippocampus]], and [[cerebellum]]. It is also found in other tissues, including the [[pancreas]] and [[heart]].
The [[KCNB1]] gene is widely expressed in the central nervous system, particularly in the [[cerebral cortex]], [[hippocampus]], and [[cerebellum]]. Its expression is crucial for maintaining normal neuronal function and excitability.
 
== Clinical Significance ==
Mutations in the KCNB1 gene have been associated with various neurological disorders, including [[epilepsy]], [[intellectual disability]], and [[autism spectrum disorder]]. These mutations can lead to either gain-of-function or loss-of-function effects, disrupting the normal electrical activity of neurons.


== Related Proteins ==
== Interactions ==
Kv2.1 is part of the larger family of voltage-gated potassium channels, which includes other subfamilies such as Kv1, Kv3, and Kv4. Each subfamily has distinct physiological roles and expression patterns.
Kv2.1 channels interact with various proteins that modulate their function and localization. These interactions are important for the precise regulation of neuronal signaling.


== Research ==
== Research ==
Ongoing research is focused on understanding the precise mechanisms by which KCNB1 mutations lead to neurological disorders. Studies are also exploring potential therapeutic interventions that can modulate Kv2.1 activity to treat these conditions.
Ongoing research is focused on understanding the detailed mechanisms by which KCNB1 mutations lead to neurological disorders. This research aims to develop targeted therapies that can correct or compensate for the dysfunctional channels.


== See Also ==
== See Also ==
* [[Voltage-gated potassium channel]]
* [[Voltage-gated potassium channel]]
* [[Neuronal action potential]]
* [[Neuronal excitability]]
* [[Epilepsy]]
* [[Epileptic encephalopathy]]
* [[Intellectual disability]]
* [[Autism spectrum disorder]]
 
== References ==
{{Reflist}}


== External Links ==
== External Links ==
{{Commons category|KCNB1}}
* [https://www.ncbi.nlm.nih.gov/gene/3745 KCNB1 Gene - NCBI]
* [https://www.omim.org/entry/616056 KCNB1 - OMIM]


[[Category:Genes]]
{{Potassium channels}}
[[Category:Genes on human chromosome 20]]
[[Category:Ion channels]]
[[Category:Ion channels]]
[[Category:Neuroscience]]
[[Category:Potassium channels]]
[[Category:Epilepsy]]
[[Category:Neurological disorders]]
[[Category:Autism spectrum disorders]]
[[Category:Membrane proteins]]
[[Category:Human proteins]]
[[Category:Medicine]]
 
{{medicine-stub}}

Latest revision as of 03:05, 9 March 2025


KCNB1
Symbol KCNB1
HGNC ID 6258
Alternative symbols
Entrez Gene 3745
OMIM 616056
RefSeq NM_004975
UniProt Q14721
Chromosome 20q13
Locus supplementary data


KCNB1 is a gene that encodes the voltage-gated potassium channel subunit Kv2.1. This channel is crucial for the regulation of electrical signaling in neurons and other excitable cells.

Function[edit]

The KCNB1 gene product, Kv2.1, is a major component of the delayed rectifier potassium current in neurons. It plays a critical role in repolarizing the membrane potential following an action potential, thereby influencing neuronal excitability and firing patterns.

Clinical Significance[edit]

Mutations in the KCNB1 gene have been associated with a range of neurological disorders, including developmental and epileptic encephalopathy. These mutations can lead to altered channel function, which disrupts normal neuronal activity and can result in seizures and developmental delays.

Structure[edit]

Kv2.1 channels are composed of four identical subunits, each containing six transmembrane segments. The channel's pore is formed by the arrangement of these subunits, allowing selective passage of potassium ions.

Expression[edit]

The KCNB1 gene is widely expressed in the central nervous system, particularly in the cerebral cortex, hippocampus, and cerebellum. Its expression is crucial for maintaining normal neuronal function and excitability.

Interactions[edit]

Kv2.1 channels interact with various proteins that modulate their function and localization. These interactions are important for the precise regulation of neuronal signaling.

Research[edit]

Ongoing research is focused on understanding the detailed mechanisms by which KCNB1 mutations lead to neurological disorders. This research aims to develop targeted therapies that can correct or compensate for the dysfunctional channels.

See Also[edit]

External Links[edit]